- Home
- VSTM vs SHLT Comparison
VSTM vs SHLT Comparison
Compare VSTM & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- SHLT
- Stock Information
- Founded
- VSTM 2010
- SHLT 1987
- Country
- VSTM United States
- SHLT Israel
- Employees
- VSTM N/A
- SHLT N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- SHLT Business Services
- Sector
- VSTM Health Care
- SHLT Consumer Discretionary
- Exchange
- VSTM Nasdaq
- SHLT Nasdaq
- Market Cap
- VSTM 132.0M
- SHLT 63.6M
- IPO Year
- VSTM 2012
- SHLT N/A
- Fundamental
- Price
- VSTM $3.88
- SHLT $2.74
- Analyst Decision
- VSTM Strong Buy
- SHLT Strong Buy
- Analyst Count
- VSTM 8
- SHLT 1
- Target Price
- VSTM $14.57
- SHLT $11.00
- AVG Volume (30 Days)
- VSTM 1.1M
- SHLT 3.2K
- Earning Date
- VSTM 11-06-2024
- SHLT 09-26-2024
- Dividend Yield
- VSTM N/A
- SHLT N/A
- EPS Growth
- VSTM N/A
- SHLT N/A
- EPS
- VSTM N/A
- SHLT N/A
- Revenue
- VSTM $10,000,000.00
- SHLT $55,939,000.00
- Revenue This Year
- VSTM N/A
- SHLT N/A
- Revenue Next Year
- VSTM $125.69
- SHLT N/A
- P/E Ratio
- VSTM N/A
- SHLT N/A
- Revenue Growth
- VSTM N/A
- SHLT N/A
- 52 Week Low
- VSTM $2.10
- SHLT $2.60
- 52 Week High
- VSTM $14.22
- SHLT $10.44
- Technical
- Relative Strength Index (RSI)
- VSTM 63.77
- SHLT 37.68
- Support Level
- VSTM $3.11
- SHLT $2.64
- Resistance Level
- VSTM $3.76
- SHLT $2.89
- Average True Range (ATR)
- VSTM 0.33
- SHLT 0.12
- MACD
- VSTM 0.04
- SHLT 0.01
- Stochastic Oscillator
- VSTM 94.26
- SHLT 23.92
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.